Research programme: tuberculosis therapy - Southern Research Institute

Drug Profile

Research programme: tuberculosis therapy - Southern Research Institute

Alternative Names: Tuberculosis therapy research programme - Southern Research Institute

Latest Information Update: 26 Jun 2003

Price : $50

At a glance

  • Originator Southern Research Institute
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Tuberculosis

Most Recent Events

  • 01 May 2001 New profile
  • 01 May 2001 Preclinical development for Tuberculosis in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top